GeneDx Holdings Corp expected to post a loss of 16 cents a share - Earnings Preview

GeneDx Holdings

11/03/2023 24:10

* GeneDx Holdings Corp  WGS.OQ   WGS.O  is expected to show
a rise
in quarterly revenue when it reports  results on March 14. 
    * The Stamford Connecticut-based  company is expected to
report  a
22.8% increase in revenue to $70.951 million from $57.8 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for GeneDx Holdings
Corp is
for a loss of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for GeneDx
Holdings
Corp is $1.5​, above​ its last closing price of $0.34. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.21       -0.21      -0.20     Beat    5.9
 Jun. 30 2022  -0.20       -0.21      -0.25     Missed  -19
 Mar. 31 2022  -0.32       -0.31      -0.31     Met     -0.4​
 Dec. 31 2021  -0.26       -0.26      -0.17     Beat    34
 ​​Sep.        -0.19       -0.19      -0.43     Missed  -128.7
 30 2021                                                
                                                        ​
 This summary was machine generated March 11 at 00:10 GMT.  All
figures in US dollars  unless otherwise stated